VICTORIA CARROLL: Open Payments
NPI 1427501857 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,381 in 89 payments from 14 companies in 2025. Trend: 2023 $1,323 · 2024 $1,412 · 2025 $1,381
Food & beverage: $1,381
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $347 |
| Otsuka America Pharmaceutical, Inc. | 18 | $281 |
| Vanda Pharmaceuticals Inc. | 10 | $160 |
| Supernus Pharmaceuticals, Inc. | 7 | $121 |
| Lundbeck LLC | 5 | $106 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Tris Pharma Inc | 2 | $31 |
Products named: TRINTELLIX, REXULTI, Qelbree, FANAPT, Auvelity, NUEDEXTA, CAPLYTA, HETLIOZ.
Industry payments across TN — which companies pay providers there.
